Neurocrine Biosciences Inc (NAS:NBIX)
$ 141.91 -0.09 (-0.06%) Market Cap: 14.28 Bil Enterprise Value: 13.59 Bil PE Ratio: 39.09 PB Ratio: 5.98 GF Score: 89/100

Neurocrine Biosciences Inc at Jefferies Virtual London Healthcare Conference Transcript

Nov 17, 2020 / 02:40PM GMT
Release Date Price: $91.75 (-1.30%)
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Welcome, everyone, to the Jefferies London Virtual Healthcare Conference. My name is Biren Amin. I'm one of the biotech analysts here at Jefferies. I'd like to introduce our next company. We have Neurocrine Biosciences, Kevin Gorman, their CEO; Matt Abernethy, CFO. And I guess Matt raided my closet and found a similar shirt this morning. So thanks for coordinating on this, Matt.

Matthew C. Abernethy
Neurocrine Biosciences, Inc. - CFO

Yes. No problem. I forgot my glasses at home, but we -- you at least have hair, and I don't. So that's one thing I'll never have again. So thanks for hosting us, and wish we were in London. It's such a beautiful time of the year. But Kevin and I are looking forward to spending time with you today.

Questions & Answers

Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Great. So let's just talk big picture. I think most investors can say that so far the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot